Netherlands· NL-b915c4f5b024
Nyxoid 1,8 mg, neusspray, oplossing
A naloxone product containing naloxonhydrochloride 2-water, registered in Netherlands by Mundipharma Corporation (Ireland) Limited. The same ATC class is registered in 11 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Naloxone is registered in 11 of 19 countries.
Countries holding a registration under ATC V03AB15 (naloxone), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Naloxone · ATC V03AB15
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- NALOXONHYDROCHLORIDE 2-WATER
- Manufacturer
- Mundipharma Corporation (Ireland) Limited
- Country
- Netherlands (NL)
- ATC code
- V03AB15
- ATC class
- Naloxone
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/17/1238
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
104 interactions on record for naloxone.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Naloxone · interactions on record
104 records
- 2 severe
- 34 moderate
- 4 minor
- 64 info
Most severe, free to view
- DroperidolN01AX01severe
- DroperidolN05AD08severe
- Methylnaltrexone bromideA06AH01moderate
- NaloxegolA06AH03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Naloxone in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandNyxoid 1,8 mg, NasensprayMundipharma Medical Company, Hamilton, Bermuda, Basel Branch
- SpainNYXOID 1,8 MG SOLUCION PARA PULVERIZACION NASAL EN ENVASE UNIDOSISMundipharma Corporation (Ireland) Limited
- FinlandNyxoidMundipharma Corporation (Ireland) Limited
- FranceNYXOID 1,8 mg, solution pour pulvérisation nasale en récipient unidoseMUNDIPHARMA CORPORATION (IRELAND)
- IcelandNyxoidMundipharma Corporation (Ireland) Limited
- PolandNyxoidMundipharma Corporation (Ireland) Limited
- SwedenNyxoid 1,8 mg Nässpray, lösningMundipharma Pharmaceuticals (Ireland) Limited
- United StatesKLOXXADOHikma Specialty USA Inc.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Forvel, Naloxon Accord
- Belgium · Naloxon B. Braun
- Bulgaria · Форвел
- Cyprus · Codaxol, Forvel
- Czechia · Forvel, Naloxone Polpharma
- Germany · Naloxon Accord, Naloxon B. Braun
- Denmark · Forvel, Naloxon B. Braun
- Estonia · Forvel, Ventizolve
- Spain · Fomed, Naloxona B. Braun
- Finland · Naloxone Accord, Nexodal
- France · Naloxone Accord, Naloxone Adapt Pharma
- United Kingdom (Northern Ireland) · Naloxone Accord-Uk, Naloxone B. Braun Melsungen
- Greece · Forvel, Νaloxon B.Braun
- Croatia · Forvel
- Hungary · Nexodal
- Ireland · Naloxone Hydrochloride Accord, Naloxone Hydrochloride Mercury Pharmaceuticals (Ireland)
- Iceland · Naloxon B. Braun, Nyxoid
- Italy · Naloxone Accord, Naloxone Adapt
- Liechtenstein · Nyxoid
- Lithuania · Forvel
- Luxembourg · Naloxon B. Braun
- Latvia · Forvel
- Malta · Forvel
- Norway · Naloxon B. Braun, Naloxon Hameln
- Poland · Naloxonum Hydrochloricum Wzf
- Portugal · Forvel, Naloxona Accord
- Romania · Forvel
- Sweden · Naloxon Actrevo, Naloxon Hameln
- Slovenia · Nexodal
- Slovakia · Naloxone Polpharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/51441ce3-c9ef-4062-9f3e-a66403f36787 GET /v1/drugs/51441ce3-c9ef-4062-9f3e-a66403f36787?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Neusspray, oplossing",
"route": "Nasaal gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/nyxoid-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Naloxone",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp120218",
"excipients": [
"NATRIUMCHLORIDE",
"NATRIUMHYDROXIDE (E 524)",
"STIKSTOF (HEAD SPACE) (E 941)",
"TRINATRIUMCITRAAT 2-WATER (E 331)",
"WATER, GEZUIVERD",
"ZOUTZUUR (E 507)"
],
"substances": [
"NALOXONHYDROCHLORIDE 2-WATER"
],
"leaflet_url": null,
"authorised_at": "2017/11/10",
"procedure_number": "EMEA/H/C/004325",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/17/1238",
"additional_monitoring": "N"
}See everything about naloxone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.